Real-time enrollment status for this major depressive disorder clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 5:17 PM UTC
| NCT Number | NCT06592833 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Last Updated on CT.gov | May 14, 2025 (May 14, 2025) |
As of July 20, 2026: Clinical trial NCT06592833 is currently recruiting participants. This phase2 study for major depressive disorder is actively seeking new participants at 1 location across the United States. The study is sponsored by Icahn School of Medicine at Mount Sinai. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06592833 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06592833 was last updated May 14, 2025 (May 14, 2025). HelloStudys verifies this status automatically.